Pharma Intermediates & Building Blocks Supplier in China
Advanced and key starting materials, heterocycles, chiral building blocks and reagents for API synthesis, from gram R&D to multi-tonne supply. API makers and CDMOs in China source key starting materials and building blocks from us for development and commercial routes.
Pharma Intermediates & Building Blocks for China
The pharma intermediates division connects API developers with India's deep base of fine-chemical manufacturers. The range includes key starting materials (KSMs), advanced intermediates for established APIs, heterocyclic building blocks such as pyridines, pyrimidines, indoles and piperazines, protected amino acids, boronic acids, chiral synthons and coupling reagents.
Supply runs from gram-scale building blocks for medicinal chemistry to kilo and multi-tonne quantities for commercial API routes. Specifications cover assay, related substances, residual solvents and, where required, enantiomeric purity or genotoxic impurity limits. Every batch ships with a COA and a GHS SDS, and route or change-control information can be discussed where the manufacturer is able to share it.
API manufacturers, CDMOs, discovery chemistry groups and agrochemical companies that share similar chemistry are typical customers. Many buyers use Indian intermediates to diversify supply chains or reduce landed cost, so we focus on consistent specifications across batches, realistic lead times and clear packaging and dangerous-goods documentation for export. Samples can usually be arranged ahead of scale-up so that buyers can run use-tests and impurity-fate studies before committing to volume. Where a molecule has several possible sources, we explain the differences in specification and documentation so buyers can choose knowingly.
Grades available
Compliance in China
Regulator: NMPA
Substances not listed on the Inventory of Existing Chemical Substances in China (IECSC) need new chemical substance registration with the Ministry of Ecology and Environment before import. Hazardous chemicals are subject to GACC (former CIQ) inspection of packaging and Chinese-language labels and SDS, and APIs need NMPA registration or linkage to a drug filing. Precursor chemicals require import licences, and dangerous goods must follow IMDG or IATA rules. APTA preference requires a certificate of origin.
Shipping lanes
- Shanghai
- Ningbo-Zhoushan
- Shenzhen
- Shanghai Pudong (PVG)
- Beijing Capital (PEK)
Typical buyers: API manufacturers, CDMOs and CMOs, Medicinal and discovery chemistry groups, Agrochemical active manufacturers, Fine-chemical traders, Academic synthesis labs.
Browse Pharma Intermediates & Building Blocks categories
Selected Pharma Intermediates & Building Blocks shipped to China
FAQs — Pharma Intermediates & Building Blocks in China
Do you supply Pharma Intermediates & Building Blocks to China?
Yes. We export Pharma Intermediates & Building Blocks to China by sea freight to Shanghai or Ningbo-Zhoushan, by air cargo, or by express courier for small R&D packs. Every shipment includes a COA and a GHS SDS.
How long does delivery to China take?
Typical sea transit from India to China is 18–26 days and air freight 3–5 days, plus production/packing lead time and customs clearance.
Can you supply intermediates to our in-house specification?
Yes. Send your specification and analytical method, and we will check whether a source can meet it and quote with a sample COA.
What scale can you supply?
From gram quantities of building blocks for R&D to kilogram and tonne-scale supply for established intermediates, depending on the product and manufacturer capacity.
Do you offer custom synthesis of intermediates?
Custom synthesis can be arranged through partner manufacturers for many structures. Feasibility, lead time and price are confirmed after reviewing the route and specification.
Other divisions for China
Pharma Intermediates & Building Blocks in nearby markets
Pharma Intermediates & Building Blocks quote — China
We reply within one business day with price, pack options, lead time and documentation.